Vancomycin heteroresistance in bloodstream isolates of Staphylococcus capitis

Journal of Clinical Microbiology

Volumn 46, Issue 9, 2008, Pages 3124-3126

  D'Mello, Danaë ^a   Daley, Andrew J ^b,d   Rahman, Muhammad Shihab ^a   Qu, Yue ^a   Garland, Suzanne ^b,c,d   Pearce, Christopher ^b   Deighton, Margaret A ^a  

^a RMIT UNIVERSITY   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; BLOOD FLOW; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; POPULATION RESEARCH; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS CAPITIS;

HUMANS; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

STAPHYLOCOCCUS CAPITIS;

EID: 53649086474     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00592-08     Document Type: Article

References (22)

1. Biavasco, F., C. Vignaroli, and P. E. Varaldo. 2000. Glycopeptide resistance in coagulase-negative staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 19:403-417.
2. Biavasco, F., C. Vignaroli, R. Lazzarini, and P. E. Varaldo. 2000. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates. Antimicrob. Agents Chemother. 44:3122-3126.
3. Bradford, R., R. Abdul Manan, A. J. Daley, C. Pearce, A. Ramalingam, D. D'mello, Y. Mueller, W. Uahwatanasakul, Y. Qu, D. Grando, S. Garland, and M. Deighton. 2006. Coagulase-negative staphylococci in very low birth weight infants: genetic markers do not distinguish invasive strains from blood culture contaminants. Eur. J. Clin. Microbiol. Infect. Dis. 5:283-290.
4. Center, K. J., A. C. Reboli, R. Hubler, G. L. Rodgers, and S. S. Long. 2003. Decreased vancomycin susceptibility of coagulase-negative staphylococci in a neonatal intensive care unit: evidence of spread of Staphylococcus warneri. J. Clin. Microbiol. 41:4660-4665.
5. Clinical Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard, 7th ed. Clinical Laboratory Standards Institute, Wayne, PA.
6. de Silva, G. D. I., M. Kantzanou, A. Justice, R. C. Massey, A. R. Wilkinson, N. P. J. Day, and S. J. Peacock. 2002. The ica operon and biofilm production in coagulase-negative staphylococci associated with carriage and disease in a neonatal intensive care unit. J. Clin. Microbiol. 40:382-388.
7. Falagas, M. E., G. C. Makris, G. Dimopoulos, and D. K. Matthaiou. 2008. Heteroresistance: a concern of increasing clinical significance? Clin. Microbiol. Infect. 14:101-104.
8. Fitzgibbon, M. M., A. S. Rossney, and B. O'Connell. 2007. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant isolates from patients in Ireland and evaluation of agar screening methods for the detection of heterogeneously glycopeptide-intermediate S. aureus. J. Clin. Microbiol. 45:2554-2563.
9. Froggatt, J. W., J. L. Johnston, D. W. Galetto, and G. L. Archer. 1989. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 33:460-466.
10. Garrett, D. O., E. Jochimsen, K. Murfitt, B. Hill, S. McAllister, P. Nelson, R. V. Spera, R. K. Sall, F. C. Tenover, J. Johnston, B. Zimmer, and W. R. Jarvis. 1999. The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect. Control Hosp. Epidemiol. 20:167-170.
11. Hanaki, H., K. Kuwahara-Arai, S. Boyle-Vavra, R. S. Daum, H. Labischinski, and K. Hiramatsu. 1998. Activated cell wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J. Antimicrob. Chemother. 42:199-209.
12. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
13. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-146.
14. Howden, B. P., P. B. Ward, P. D. R. Johnson, P. P. Charles, and M. L. Grayson. 2005. Low-level vancomycin resistance in Staphylococcus aureus - an Australian perspective. Eur. J. Clin. Microbiol. Infect. Dis. 24:100-108.
15. Liu, C., and H. F. Chambers. 2003. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob. Agents Chemother. 47: 3040-3045.
16. Ng, P. C., V. C. Y. Chow, C. H. Lee, J. M. L. Ling, H. L. Wong, and R. C. Y. Chan. 2006. Persistent Staphylococcus capitis septicaemia in a preterm infant. Pediatr. Infect. Dis. J. 25:652-654.
17. Sieradzki, K., P. Villari, and A. Tomasz. 1998. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 42:100-110.
18. Van Der Zwet, W. C., Y. J. Debets-Ossenkopp, E. Reinders, M. Kapi, P. H. M. Savelkoul, R. M. Van Elburg, K. Hiramatsu, and C. M. J. E. Vandenbroucke-Grauls. 2002. Nosocomial spread of a Staphylococcus capitis strain with heteroresistance to vancomycin in a neonatal intensive care unit. J. Clin. Microbiol. 40:2520-2525.
19. Walsh, T. R., A. Bolmström, A. Qwärnström, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.
20. Wang, S.-M., C.-C. Liu, H.-W. Tseng, Y.-J. Yang, C.-H. Lin, A.-Y. Huang, and Y.-H. Wu. 1999. Staphylococcus capitis bacteremia of very low birth weight premature infants at neonatal intensive care units: clinical significance and antimicrobial susceptibility. J. Immunol. Infect. 32:26-32.
21. Wooton, M., R. A. Howe, R. Hillman, T. R. Walsh, P. M. Bennett, and W. MacGowan. 2001. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother. 47:399-403.
22. Wooton, M., A. P. MacGowan, T. R. Walsh, and R. A. Howe. 2007. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 45:329-332.